tiprankstipranks
Advertisement
Advertisement
After Forte acquisition, H.C. Wainwright says First Tracks could be target
PremiumThe FlyAfter Forte acquisition, H.C. Wainwright says First Tracks could be target
5d ago
Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
Premium
The Fly
Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
5d ago
Forte Biosciences downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Forte Biosciences downgraded to In Line from Outperform at Evercore ISI
5d ago
Argenx to acquire Forte Biosciences for $77 per share in cash
PremiumThe FlyArgenx to acquire Forte Biosciences for $77 per share in cash
5d ago
Argenx Expands Myasthenia Gravis Pipeline With New Empasiprubart Phase 2a Trial
Premium
Company Announcements
Argenx Expands Myasthenia Gravis Pipeline With New Empasiprubart Phase 2a Trial
8d ago
Argenx Completes Key Phase 2/3 Efgartigimod Study in Rare Muscle Disease
Premium
Company Announcements
Argenx Completes Key Phase 2/3 Efgartigimod Study in Rare Muscle Disease
8d ago
Argenx price target raised to $1,037 from $1,014 at Oppenheimer
PremiumThe FlyArgenx price target raised to $1,037 from $1,014 at Oppenheimer
8d ago
Argenx price target raised to $1,065 from $955 at Leerink
Premium
The Fly
Argenx price target raised to $1,065 from $955 at Leerink
8d ago
Argenx price target raised to $1,185 from $1,135 at Guggenheim
Premium
The Fly
Argenx price target raised to $1,185 from $1,135 at Guggenheim
8d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100